| UP Ident. |
Protein code |
Av Pep |
Males 3A |
Males 3B |
Males 4 |
Females 3A |
Females 3B+4 |
UnLab |
BC |
| P02763 |
ORM1 |
25 |
6.0* ± 0.5 |
1.9* ± 0.1 |
3.6* ± 0.2 |
8.3* ± 0.1 |
6.9* ± 0.5 |
Yes |
No |
| C9JF17 |
APOD |
12 |
1.4 ± 0.2 |
0.2* ± 0.1 |
0.6 ± 0.1 |
1.2 ± 0.2 |
0.4* ± 0.1 |
No |
Yes |
| P98160 |
HSPG2 |
14 |
1.3 ± 0.2 |
0.5* ± 0.1 |
0.8 ± 0.1 |
0.9 ± 0.1 |
0.5 ± 0.1 |
No |
Yes |
| Q6FHM9 |
CD59 |
12 |
0.7 ± 0.1 |
0.3* ± 0.1 |
0.6* ± 0.1 |
1.2 ± 0.1 |
0.7 ± 0.1 |
No |
Yes |
| E9KL23 |
|
12 |
1.4 ± 0.0 |
2.2* ± 0.3 |
0.5* ± 0.1 |
4.2* ± 0.4 |
0.7 ± 0.0 |
Yes |
Yes |
| P00738 |
HP |
5 |
3.3* ± 0.1 |
1.0 ± 0.3 |
2.3* ± 0.2 |
8.7 ± 0.0 |
2.3* ± 0.7 |
No |
No |
| D3DNU8 |
KNG1 |
19 |
0.4* ± 0.1 |
0.2* ± 0.1 |
0.2* ± 0.1 |
0.6 ± 0.1 |
0.2* ± 0.0 |
Yes |
Yes |
| P15309 |
ACPP |
6 |
0.2* ± 0.1 |
0.2* ± 0.1 |
0.8 ± 0.0 |
0.9 ± 0.2 |
0.5 ± 0.2 |
No |
No |
| P02760 |
AMBP |
74 |
2.0* ± 0.1 |
0.4* ± 0.1 |
2.3* ± 0.0 |
2.1* ± 0.3 |
1.2 ± 0.1 |
Yes |
Yes |
| Q8TCD0 |
“PUP” |
7 |
1.6 ± 0.4 |
0.6 ± 0.0 |
1.7 ± 0.5 |
1.9* ± 0.2 |
1.5* ± 0.3 |
Yes |
Yes |
| P02768 |
ALB |
302 |
3.1* ± 0.2 |
4.6* ± 0.0 |
2.3* ± 0.2 |
4.2* ± 0.2 |
2.8* ± 0.3 |
Yes |
N/A |
| E9PEA4 |
UMOD |
39 |
2.2* ± 0.1 |
0.2* ± 0.1 |
0.2* ± 0.1 |
0.7 ± 0.0 |
0.1* ± 0.0 |
No |
No |
| P25311 |
AZGP1 |
21 |
3.7* ± 0.5 |
0.6* ± 0.1 |
2.7* ± 0.2 |
3.2* ± 0.4 |
2.4* ± 0.4 |
Yes |
Yes |
UP Ident. = UniProt identifier; Av Pep = average number of peptides; Males 3A = CKD stage 3A ratio CKD males:control males; similarly, for Males 3B and Males 4;
Females 3A = CKD stage 3A ratio CKD females:control females; similarly, for Females 3B+4; UnLab = identified by unlabelled approach in all tested groups; BC = biomarker
candidate.
* = p<0.05 |
